Epilepsies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-06-08
EMA Authorised: Fintepla (fenfluramine hydrochloride) — UCB Pharma S.A.
The EMA authorised Fintepla (fenfluramine hydrochloride) from UCB Pharma S.A. for epilepsies with myoclonic seizures, an orphan medicine des…